Cargando…

SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia

BACKGROUND: SARS-CoV-2 antibody testing is required for estimating population seroprevalence and vaccine response studies. It may also increase case identification when used as an adjunct to routine molecular testing. We performed a validation study and evaluated the use of automated high-throughput...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sekirov, Inna, Barakauskas, Vilte E., Simons, Janet, Cook, Darrel, Bates, Brandon, Burns, Laura, Masud, Shazia, Charles, Marthe, McLennan, Meghan, Mak, Annie, Chahil, Navdeep, Vijh, Rohit, Hayden, Althea, Goldfarb, David, Levett, Paul N, Krajden, Mel, Morshed, Muhammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282439/ https://www.ncbi.nlm.nih.gov/pubmed/34304088 http://dx.doi.org/10.1016/j.jcv.2021.104914

Ejemplares similares

Serological survey following SARS-COV-2 outbreaks at long-term care facilities in metro Vancouver, British Columbia: Implications for outbreak management and infection control policies
por: Vijh, Rohit, et al.
Publicado: (2021)

Comparative Analysis of Capillary vs Venous Blood for Serologic Detection of SARS-CoV-2 Antibodies by RPOC Lateral Flow Tests
por: Morshed, Muhammad, et al.
Publicado: (2021)

British Columbia’s Experience after Implementation of the Treponema pallidum Reverse Algorithm and PCR Detection, 2015 to 2020
por: Morshed, Muhammad, et al.
Publicado: (2022)

Population SARS-CoV-2 Seroprevalence Using Antenatal Serum Samples in British Columbia, Canada
por: McClymont, Elisabeth, et al.
Publicado: (2021)

Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks
por: Tanunliong, Guadalein, et al.
Publicado: (2022)

Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella–Zoster Diagnosis
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022)

Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies
por: Sekirov, Inna, et al.
Publicado: (2021)

An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccinees
por: Liu, Binjian, et al.
Publicado: (2022)

Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada
por: Tanunliong, Guadalein, et al.
Publicado: (2022)

Evaluation of the Chagas VirClia(®) and Chagas TESA VirClia(®) for the Diagnosis of Trypanosoma cruzi Infection
por: García-Bermejo, Isabel, et al.
Publicado: (2022)

Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
por: Skowronski, Danuta M., et al.
Publicado: (2022)

Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response
por: Nikiforuk, Aidan M., et al.
Publicado: (2022)

Erratum for Nikiforuk et al., “Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response”
por: Nikiforuk, Aidan M., et al.
Publicado: (2022)

Towards targeted screening for acute HIV infections in British Columbia
por: Steinberg, Malcolm, et al.
Publicado: (2011)

Targeting screening and social marketing to increase detection of acute HIV infection in men who have sex with men in Vancouver, British Columbia
por: Gilbert, Mark, et al.
Publicado: (2013)

CLIA-certified next-generation sequencing analysis in the cloud
por: Zhang, Ying, et al.
Publicado: (2012)

Effect of storage temperatures simulating transport conditions of nasopharyngeal swabs on the results of a chemiluminescence immunoassay (CLIA) to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen
por: Kanta, Poonam, et al.
Publicado: (2023)

CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis
por: Rieken, Autumn, et al.
Publicado: (2021)

Effectiveness of Latent TB Screening and Treatment in People Initiating Dialysis in British Columbia, Canada
por: Romanowski, Kamila, et al.
Publicado: (2020)

Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities
por: Klepser, Nicklas S., et al.
Publicado: (2021)

Corrigendum to ‘An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccines ’ [International Journal of Infectious Diseases, Volume 115, 2022, Pages 116-125, ISSN 1201-9712]()
por: Liu, Binjian, et al.
Publicado: (2022)

The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
por: Janjua, Naveed Z., et al.
Publicado: (2016)

HCV co-infection in HIV positive population in British Columbia, Canada
por: Buxton, Jane A, et al.
Publicado: (2010)

A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG
por: Li, Fang Fang, et al.
Publicado: (2022)

Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada
por: Romanowski, Kamila, et al.
Publicado: (2017)

Ability of community pharmacists to independently perform CLIA-waived testing – A multistate legal review
por: Doucette, Joseph, et al.
Publicado: (2021)

Determination of vitamin D status in singleton and twin gestations using CLIA and LC-MS/MS
por: Zgliczyńska, Magdalena, et al.
Publicado: (2023)

The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada
por: Nikiforuk, Aidan M., et al.
Publicado: (2021)

Canadian antenatal COVID-19 seroprevalence study; population mapping of the COVID-19 pandemic utilizing stored antenatal sera
por: A, Atkinson, et al.
Publicado: (2023)

Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study
por: Olmstead, Andrea D., et al.
Publicado: (2022)

A Comparative Serological Study of Toxoplasmosis in Pregnant Women by CLIA and ELISA Methods in Chalus City Iran
por: Elahian Firouz, Zahra, et al.
Publicado: (2014)

Clinical validation of the novel CLIA-CA-62 assay efficacy for early-stage breast cancer detection
por: Sekacheva, Marina, et al.
Publicado: (2023)

Detection of Early Sero-Conversion HIV Infection Using the INSTI(TM) HIV-1 Antibody Point-of-Care Test
por: Cook, Darrel, et al.
Publicado: (2010)

Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort study
por: Gottschlich, Anna, et al.
Publicado: (2023)

Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study
por: Wilton, James, et al.
Publicado: (2020)

Comparative Evaluation and Measure of Accuracy of ELISAs, CLIAs, and ECLIAs for the Detection of HIV Infection among Blood Donors in China
por: Chang, Le, et al.
Publicado: (2020)

Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants
por: Janjua, Naveed Zafar, et al.
Publicado: (2016)

SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada
por: Watts, Allison W, et al.
Publicado: (2023)

Clinical diagnostic performance of light‐initiated chemiluminescent assay compared with the Architect chemiluminescence immunoassay for detection of HCV antibody
por: Yang, Shuo, et al.
Publicado: (2019)

Evaluation of a new chemiluminescence immunoassay for diagnosis of syphilis
por: Mo, Xiaohui, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_p5ubdl8oqb9h8vmmg8spvgirp5